Nantechnology is rapidly becoming popular as the new trend in medical diagnosis and treatment. Why? Because, it essentially allows one to literally make diagnosis and even initiate targeted treatment sooner than by way of traditional forms of medical care.
We would like to announce our future project to engage primarily in early diagnosis of disease through nanotechnology. This technology allows one to use nano-particles (such as gold or silver), which are really tiny matter that can label a particular tumor to be visualized IN-SITU (or simply in its native form in the body) without undergoing a surgical biopsy. In other words, through the manipulation of atoms, we can label potential tumors, for example, as small as a few nanometers, which are smaller than a cell (for instance, a red blood cell is 7 micrometers in diameter which is 7,000 x larger than object measuring 1 nanometer). Most tumors in the beginning stages of cancer make certain proteins which can be used as markers of tumor development and manifestation (oncogenesis).. Since tumor cells aggregate in “MASSES,” the volume of protein expressed through digital imagery, i.e. ultrasound or CT-scan or via other more specialized imaging pathways, could be standardized to make diagnosis at the molecular level, before a tumor becomes large enough that would eventually limit successful treatment outcome. Thus, this would lead to destroying a potential tumor cell in its earliest molecular development. This would be an objective basis for disease diagnosis, and may lead to curing many different types of aggressive cancer before reaching detectible size by current traditional medical means.
We plan to discuss the details with a legitimate, potential investment capital group.
We at MDC-Atlanta remain committed to keeping our patients informed for better quality and safe medical care.